• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The antenatal prevention of congenital syphilis in a peri-urban settlement.

作者信息

Swingler G H, Van Coeverden de Groot H A

机构信息

Department of Paediatrics and Child Health, Groote Schuur Hospital.

出版信息

S Afr Med J. 1993 Jan;83(1):34-5.

PMID:8424199
Abstract

The obstetric records of patients from Khayelitsha were examined to assess the efficiency of a system for the antenatal prevention of congenital syphilis, and to identify points of breakdown in the process. Seventy-seven (12.7%) of 607 mothers had serological evidence of syphilis, including 10 (32.3%) of 31 mothers who had received no antenatal care. Of 70 patients who required routine management, only 36 (51.4%) received 3 or more of the recommended 4 penicillin injections. Two main weaknesses in the system were identified. One was the centralisation of serological testing. This delayed results reaching the relevant unit, and was responsible for a high cumulative attrition of patients during the many stages necessitated by the centralised testing. The other was a 24.5% attrition of patients referred from the antenatal clinic to a separate sexually transmitted diseases clinic.

摘要

相似文献

1
The antenatal prevention of congenital syphilis in a peri-urban settlement.
S Afr Med J. 1993 Jan;83(1):34-5.
2
Maternal and congenital syphilis programmes: case studies in Bolivia, Kenya and South Africa.孕产妇和先天性梅毒防治项目:玻利维亚、肯尼亚和南非的案例研究
Bull World Health Organ. 2004 Jun;82(6):410-6.
3
Congenital syphilis: identification of two distinct profiles of maternal characteristics associated with risk.先天性梅毒:与风险相关的两种不同母体特征概况的识别。
Sex Transm Dis. 2004 Jan;31(1):33-7. doi: 10.1097/01.OLQ.0000105003.72411.FB.
4
[Assessment of the congenital syphilis prevention programs].[先天性梅毒预防项目评估]
Rev Med Chir Soc Med Nat Iasi. 2011 Jul-Sep;115(3):934-7.
5
Outcome of maternal syphilis at Rajavithi Hospital on offsprings.拉贾维蒂医院母婴梅毒对后代的影响。
J Med Assoc Thai. 2005 Nov;88(11):1519-25.
6
The prevention and management of congenital syphilis: an overview and recommendations.先天性梅毒的预防与管理:概述与建议
Bull World Health Organ. 2004 Jun;82(6):424-30.
7
Coverage of antenatal syphilis screening and predictors for not being screened in Ulaanbaatar, Mongolia.蒙古国乌兰巴托市产前梅毒筛查覆盖率及未接受筛查的预测因素
Sex Transm Dis. 2006 May;33(5):284-8. doi: 10.1097/01.olq.0000194577.71693.c7.
8
Missed opportunities for preventing congenital syphilis infection in New York City.纽约市预防先天性梅毒感染的错失机会。
Obstet Gynecol. 2012 Oct;120(4):882-8. doi: 10.1097/AOG.0b013e31826ac25f.
9
Congenital syphilis as a notifiable disease.先天性梅毒作为一种应报告疾病。
S Afr Med J. 1993 Oct;83(10):721-3.
10
Early congenital syphilis--a continuing problem in Malaysia.早期先天性梅毒——马来西亚的一个持续存在的问题。
Med J Malaysia. 1995 Jun;50(2):131-5.

引用本文的文献

1
Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: a randomised controlled trial.南非农村地区孕产妇梅毒现场检测对治疗延迟、治疗率及围产期死亡率的影响:一项随机对照试验
Sex Transm Infect. 2003 Jun;79(3):208-13. doi: 10.1136/sti.79.3.208.
2
Whole-blood hemagglutination inhibition test for venereal disease research laboratory (VDRL) antibodies.性病研究实验室(VDRL)抗体的全血血凝抑制试验。
J Clin Microbiol. 2000 Sep;38(9):3413-4. doi: 10.1128/JCM.38.9.3413-3414.2000.
3
The decentralization of syphilis screening for improved care in Jamaican public clinics. Collaborative Working Group on Decentralized Syphilis Screening.
牙买加公共诊所梅毒筛查的去中心化以改善医疗服务。去中心化梅毒筛查协作工作组。
Am J Public Health. 1997 Jun;87(6):1019-21. doi: 10.2105/ajph.87.6.1019.
4
Chest radiographs of neonates with respiratory failure caused by congenital syphilis.
Pediatr Radiol. 1995;25(3):198-200. doi: 10.1007/BF02021534.